Asthma in Pregnancy: Treatment & Management Guidelines

March 19, 2026 Ananya Mittal - World Editor

Asthma during pregnancy requires careful management, with corticosteroids and short-acting beta agonists remaining the cornerstone of treatment. This approach ensures both the well-being of the mother and the developing child. Understanding the nuances of asthma control in expectant mothers is crucial for clinicians, as effective management can significantly reduce risks associated with both the condition itself and its treatment.

The Interplay of Corticosteroids and Beta-Agonists

The management of asthma relies heavily on two classes of medications: corticosteroids and beta-agonists. Corticosteroids reduce inflammation in the airways, while beta-agonists relax the muscles surrounding the airways, opening them up for easier breathing. These medications aren’t new to asthma treatment, but their application in pregnancy requires a nuanced understanding. The pharmacology of both has been extensively studied, with current focus shifting to how they interact during disease development and exacerbation, particularly in vulnerable populations like pregnant women. Research concentrates on the mechanisms affecting these interactions.

Short-acting beta-agonists (SABAs) are typically used for quick relief of asthma symptoms, while inhaled corticosteroids (ICS) are used for long-term control. Recent approaches, like single maintenance and reliever therapy (SMART), explore combining ICS and long-acting beta-agonists (LABAs) for both control and quick relief, though the specific application of SMART in pregnancy requires individualized assessment. Studies suggest this combined approach can be effective for persistent asthma, but its safety profile during pregnancy needs careful consideration.

Asthma in Pregnancy: A Complex Landscape

The physiological changes of pregnancy can significantly impact asthma. Increased blood volume and cardiac output, coupled with hormonal shifts, can sometimes worsen asthma symptoms. Conversely, asthma itself can pose risks to both mother and baby, including preeclampsia, gestational diabetes, preterm birth, and low birth weight. Maintaining optimal asthma control throughout pregnancy is paramount.

The Global Initiative for Asthma (GINA) guidelines recommend a stepped approach to asthma management, tailoring treatment to the severity of the condition. Beta-2 agonists, used alongside steroids, are considered essential for managing symptoms and reducing long-term risks in asthma patients, including those who are pregnant. Recent revisions to these guidelines emphasize the importance of a clear understanding of these medications’ mechanisms and appropriate use.

What Clinicians Need to Know: A Practical Approach

For clinicians, several key considerations apply when managing asthma in pregnancy:

  • Assessment of Asthma Control: Regularly assess asthma control using validated questionnaires and objective measures like peak flow monitoring.
  • Medication Safety: While most asthma medications are considered safe during pregnancy, it’s crucial to use the lowest effective dose. The potential risks of uncontrolled asthma generally outweigh the risks of medication.
  • Patient Education: Educate pregnant patients about the importance of adherence to their medication regimen and recognizing early signs of asthma exacerbation.
  • Monitoring for Complications: Closely monitor for potential complications of both asthma and pregnancy.
  • Individualized Treatment Plans: Develop individualized treatment plans based on the patient’s asthma severity, response to treatment, and overall health status.

Understanding the Risks and Benefits

It’s crucial to remember that uncontrolled asthma poses a greater risk to both mother and baby than the medications used to treat it. While there are potential side effects associated with corticosteroids and beta-agonists, these are generally minimal at the doses used for asthma management. The benefits of controlling asthma – preventing exacerbations, improving oxygenation, and reducing the risk of complications – typically outweigh the risks.

The decision to use any medication during pregnancy should be made on a case-by-case basis, considering the individual patient’s circumstances and the potential risks and benefits. Open communication between the clinician and the patient is essential.

The Evolving Landscape of Asthma Management

Research into asthma management continues to evolve. New therapies and approaches are being investigated, and guidelines are regularly updated to reflect the latest evidence. Clinicians should stay abreast of these developments to provide the best possible care for their patients. The focus remains on personalized medicine, tailoring treatment to the individual needs of each patient, particularly in the context of pregnancy.

What comes next: Ongoing research is focused on refining asthma management strategies during pregnancy, including exploring the optimal use of biomarkers to predict exacerbations and personalize treatment. Regular reviews of clinical guidelines are as well essential to ensure they reflect the latest evidence and best practices. Clinicians should consult the most current guidelines from organizations like GINA and national asthma organizations for the most up-to-date recommendations.